{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:22:54Z","timestamp":1792174974066,"version":"4.4.0"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,3]]},"abstract":"<jats:p>Pheochromocytomas (PCCs) and abdominal paragangliomas (PGLs), collectively abbreviated PPGL, are believed to exhibit malignant potential\u2014but only subsets of cases will display full-blown malignant properties. The Pheochromocytoma of the Adrenal Gland Scaled Score (PASS) algorithm is a proposed histologic system to detect potential for aggressive behavior, but little is known regarding the coupling to underlying molecular genetics. In this study, a total of 92 PPGLs, previously characterized for susceptibility gene status and mRNA expressional profiles, were histologically assessed using the PASS criteria. A total of 32\/92 PPGLs (35%) exhibited a PASS score \u22654, including all 8 cases with malignant behavior (7 with known metastases and 1 with extensively infiltrative local recurrence). Statistical analyzes between expressional data and clinical parameters as well as individual PASS criteria yielded significant associations to <jats:italic toggle=\"yes\">Chromogranin B<\/jats:italic> (<jats:italic toggle=\"yes\">CHGB<\/jats:italic>), <jats:italic toggle=\"yes\">BRCA2<\/jats:italic>, <jats:italic toggle=\"yes\">HIST1H3B<\/jats:italic>, <jats:italic toggle=\"yes\">BUB1B<\/jats:italic>, and <jats:italic toggle=\"yes\">RET<\/jats:italic> to name a few, and <jats:italic toggle=\"yes\">CHGB<\/jats:italic> had the strongest correlation to both PASS and metastasis\/local recurrence of all analyzed genes. Evident <jats:italic toggle=\"yes\">CHGB<\/jats:italic> downregulation was observed in PPGLs with high PASS and overtly malignant behavior, and was also associated with shorter disease-related survival. This finding was validated using quantitative real-time polymerase chain reaction, in which <jats:italic toggle=\"yes\">CHGB<\/jats:italic> expression correlated with both PASS and metastasis\/local recurrence with consistent findings obtained in the TCGA cohort. Moreover, immunohistochemical analyses of subsets of tumors showed a correlation between high PASS scores and negative or weak CHGB protein expression. Patients with PPGLs obtaining high PASS scores postoperatively, also exhibited low preoperative plasma levels of CHGB. These data collectively point out CHGB as a possible preoperative and postoperative marker for PPGLs with potential for aggressive behavior.<\/jats:p>","DOI":"10.1097\/pas.0000000000001190","type":"journal-article","created":{"date-parts":[[2018,11,17]],"date-time":"2018-11-17T16:29:06Z","timestamp":1542472146000},"page":"409-421","source":"Crossref","is-referenced-by-count":30,"title":["Molecular Profiling of Pheochromocytoma and Abdominal Paraganglioma Stratified by the PASS Algorithm Reveals Chromogranin B as Associated With Histologic Prediction of Malignant Behavior"],"prefix":"10.1097","volume":"43","author":[{"given":"Adam","family":"Stenman","sequence":"first","affiliation":[{"name":"Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital, CCK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrika","family":"Svahn","sequence":"additional","affiliation":[{"name":"Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital, CCK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Hojjat-Farsangi","sequence":"additional","affiliation":[{"name":"Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital, CCK"},{"name":"Department of Immunology, The Persian Gulf Marine Biotechnology Medicine Research Center, School of Medicine, Bushehr University of Medical Sciences, Bushehr, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Zedenius","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine and Surgery, Karolinska Institutet"},{"name":"Department of Breast and Endocrine Surgery, Karolinska University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"S\u00f6derkvist","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, Division of Cell Biology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Gimm","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, Division of Cell Biology"},{"name":"Department of Surgery, Medical Faculty, Link\u00f6ping University, Link\u00f6ping, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catharina","family":"Larsson","sequence":"additional","affiliation":[{"name":"Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital, CCK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Christofer","family":"Juhlin","sequence":"additional","affiliation":[{"name":"Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital, CCK"},{"name":"Department of Pathology and Cytology, Karolinska University Hospital, Stockholm"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230922","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrendo.2014.188","article-title":"Paraganglioma and phaeochromocytoma: from genetics to personalized medicine","volume":"11","author":"Favier","year":"2015","journal-title":"Nat Rev Endocrinol"},{"key":"R2-20230922","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nrc3648","article-title":"Pheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneity","volume":"14","author":"Dahia","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"R3-20230922","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1158\/0008-5472.CAN-17-2463","article-title":"Germline mutations in the mitochondrial 2-oxoglutarate\/malate carrier SLC25A11 gene confer a predisposition to metastatic paragangliomas","volume":"78","author":"Buffet","year":"2018","journal-title":"Cancer Res"},{"key":"R4-20230922","doi-asserted-by":"crossref","first-page":"E1352","DOI":"10.1210\/jc.2013-4375","article-title":"Rare germline mutations identified by targeted next-generation sequencing of susceptibility genes in pheochromocytoma and paraganglioma","volume":"99","author":"Welander","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"R5-20230922","doi-asserted-by":"crossref","first-page":"5406","DOI":"10.1093\/hmg\/dds402","article-title":"Integrative genomics reveals frequent somatic NF1 mutations in sporadic pheochromocytomas","volume":"21","author":"Welander","year":"2012","journal-title":"Hum Mol Genet"},{"key":"R6-20230922","doi-asserted-by":"crossref","first-page":"3974","DOI":"10.1093\/hmg\/ddr324","article-title":"Integrative genomic analysis reveals somatic mutations in pheochromocytoma and paraganglioma","volume":"20","author":"Burnichon","year":"2011","journal-title":"Hum Mol Genet"},{"key":"R7-20230922","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ccell.2017.01.001","article-title":"Comprehensive molecular characterization of pheochromocytoma and paraganglioma","volume":"31","author":"Fishbein","year":"2017","journal-title":"Cancer Cell"},{"key":"R8-20230922","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00423-011-0880-x","article-title":"Malignant pheochromocytomas and paragangliomas: a diagnostic challenge","volume":"397","author":"Gimm","year":"2012","journal-title":"Langenbecks Arch Surg"},{"key":"R10-20230922","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/00000478-200205000-00002","article-title":"Pheochromocytoma of the Adrenal gland Scaled Score (PASS) to separate benign from malignant neoplasms: a clinicopathologic and immunophenotypic study of 100 cases","volume":"26","author":"Thompson","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"R11-20230922","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1530\/ERC-13-0494","article-title":"Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma","volume":"21","author":"Kimura","year":"2014","journal-title":"Endocr Relat Cancer"},{"key":"R12-20230922","doi-asserted-by":"crossref","first-page":"e0168413","DOI":"10.1371\/journal.pone.0168413","article-title":"Disentangling of malignancy from benign pheochromocytomas\/paragangliomas","volume":"11","author":"Kim","year":"2016","journal-title":"PloS One"},{"key":"R13-20230922","first-page":"EC01","article-title":"Risk stratification in paragangliomas with PASS (Pheochromocytoma of the Adrenal Gland Scaled Score) and immunohistochemical markers","volume":"10","author":"Kulkarni","year":"2016","journal-title":"J Clin Diagn Res"},{"key":"R14-20230922","doi-asserted-by":"crossref","DOI":"10.1007\/s12022-018-9544-5","article-title":"Catecholamine-synthesizing enzymes in pheochromocytoma and extraadrenal paraganglioma","author":"Konosu-Fukaya","year":"2018","journal-title":"Endocr Pathol"},{"key":"R15-20230922","first-page":"65","article-title":"Acquired hypermethylation of the P16INK4A promoter in abdominal paraganglioma: relation to adverse tumor phenotype and predisposing mutation","volume":"18","author":"Kiss","year":"2013","journal-title":"Endocr Relat Cancer"},{"key":"R16-20230922","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1530\/ERC-13-0384","article-title":"Frequent EPAS1\/HIF2\u03b1 exons 9 and 12 mutations in non-familial pheochromocytoma","volume":"21","author":"Welander","year":"2014","journal-title":"Endocr Relat Cancer"},{"key":"R17-20230922","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/gcc.22347","article-title":"HRAS mutation prevalence and associated expression patterns in pheochromocytoma","volume":"55","author":"Stenman","year":"2016","journal-title":"Genes Chromosomes Cancer"},{"key":"R18-20230922","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/s00268-017-4320-0","article-title":"Activating FGFR1 mutations in sporadic pheochromocytomas","volume":"42","author":"Welander","year":"2018","journal-title":"World J Surg"},{"key":"R19-20230922","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1126\/science.1235122","article-title":"Cancer genome landscapes","volume":"339","author":"Vogelstein","year":"2013","journal-title":"Science"},{"key":"R20-20230922","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/path.2440","article-title":"The Human Protein Atlas\u2014a tool for pathology","volume":"216","author":"Pont\u00e9n","year":"2008","journal-title":"J Pathol"},{"key":"R21-20230922","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1530\/eje.0.1360067","article-title":"Chromogranin A and chromogranin B are sensitive circulating markers for phaeochromocytoma","volume":"136","author":"Stridsberg","year":"1997","journal-title":"Eur J Endocrinol"},{"key":"R22-20230922","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1677\/joe.0.1440049","article-title":"Measurements of chromogranin A, chromogranin B (secretogranin I), chromogranin C (secretogranin II) and pancreastatin in plasma and urine from patients with carcinoid tumours and endocrine pancreatic tumours","volume":"144","author":"Stridsberg","year":"1995","journal-title":"J Endocrinol"},{"key":"R23-20230922","doi-asserted-by":"crossref","first-page":"e0187398","DOI":"10.1371\/journal.pone.0187398","article-title":"Validation of pathological grading systems for predicting metastatic potential in pheochromocytoma and paraganglioma","volume":"12","author":"Koh","year":"2017","journal-title":"PloS One"},{"key":"R24-20230922","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1007\/s00268-010-0744-5","article-title":"Size of the tumor and Pheochromocytoma of the Adrenal Gland Scaled Score (PASS): can they predict malignancy?","volume":"34","author":"Agarwal","year":"2010","journal-title":"World J Surg"},{"key":"R25-20230922","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nrendo.2014.41","article-title":"Neuroendocrine cancer. Closing the GAPP on predicting metastases","volume":"10","author":"Eisenhofer","year":"2014","journal-title":"Nat Rev Endocrinol"},{"key":"R26-20230922","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/PAS.0b013e318190d12e","article-title":"Observer variation in the application of the Pheochromocytoma of the Adrenal Gland Scaled Score","volume":"33","author":"Wu","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"R27-20230922","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1158\/1078-0432.CCR-15-1841","article-title":"Recurrent mutations of chromatin-remodeling genes and kinase receptors in pheochromocytomas and paragangliomas","volume":"22","author":"Toledo","year":"2016","journal-title":"Clin Cancer Res"},{"key":"R28-20230922","doi-asserted-by":"crossref","first-page":"38777","DOI":"10.18632\/oncotarget.6091","article-title":"Inactivation of SDH and FH cause loss of 5hmC and increased H3K9me3 in paraganglioma\/pheochromocytoma and smooth muscle tumors","volume":"6","author":"Hoekstra","year":"2015","journal-title":"Oncotarget"},{"key":"R29-20230922","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/gcc.22267","article-title":"Whole-exome sequencing defines the mutational landscape of pheochromocytoma and identifies KMT2D as a recurrently mutated gene","volume":"54","author":"Juhlin","year":"2015","journal-title":"Genes Chromosomes Cancer"},{"key":"R30-20230922","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s12022-017-9479-2","article-title":"Malignancy in pheochromocytoma or paraganglioma: integrative analysis of 176 cases in TCGA","volume":"28","author":"Suh","year":"2017","journal-title":"Endocr Pathol"},{"key":"R31-20230922","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1210\/jc.2017-01314","article-title":"Expression of contactin 4 is associated with malignant behavior in pheochromocytomas and paragangliomas","volume":"103","author":"Evenepoel","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"R32-20230922","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1002\/j.1460-2075.1987.tb02355.x","article-title":"The primary structure of human secretogranin I (chromogranin B): comparison with chromogranin A reveals homologous terminal domains and a large intervening variable region","volume":"6","author":"Benedum","year":"1987","journal-title":"EMBO J"},{"key":"R33-20230922","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1097\/00000478-198811000-00008","article-title":"Immunological studies on the occurrence and properties of chromogranin A and B and secretogranin II in endocrine tumors","volume":"12","author":"Weiler","year":"1988","journal-title":"Am J Surg Pathol"},{"key":"R34-20230922","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/j.1600-0463.2004.t01-1-apm1121005.x","article-title":"Expression of chromogranins A, B, and C (secretogranin II) in human adrenal medulla and in benign and malignant pheochromocytomas. An immunohistochemical study with region-specific antibodies","volume":"112","author":"Portela-Gomes","year":"2004","journal-title":"Acta Pathol Microbiol Immunol Scand"},{"key":"R35-20230922","doi-asserted-by":"crossref","DOI":"10.1126\/science.aal3753","article-title":"Multipotent peripheral glial cells generate neuroendocrine cells of the adrenal medulla","volume":"357","author":"Furlan","year":"2017","journal-title":"Science"},{"key":"R36-20230922","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1677\/ERC-06-0038","article-title":"Proteomic profiling of von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2 pheochromocytomas reveals different expression of chromogranin B","volume":"14","author":"Brouwers","year":"2007","journal-title":"Endocr Relat Cancer"},{"key":"R37-20230922","doi-asserted-by":"crossref","first-page":"49699","DOI":"10.1074\/jbc.M309307200","article-title":"A functional interaction between chromogranin B and the inositol 1,4,5-trisphosphate receptor\/Ca2+ channel","volume":"278","author":"Thrower","year":"2003","journal-title":"J Biol Chem"},{"key":"R38-20230922","doi-asserted-by":"crossref","first-page":"16011","DOI":"10.1074\/jbc.M105594200","article-title":"Localization of the secretory granule marker protein chromogranin B in the nucleus. Potential role in transcription control","volume":"277","author":"Yoo","year":"2002","journal-title":"J Biol Chem"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00000478-201903000-00014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T22:45:28Z","timestamp":1695422728000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000478-201903000-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000001190","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]}}}